|
May 1
|
ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024
|
|
Apr 4
|
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
|
|
Apr 3
|
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
|
|
Apr 1
|
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
|
|
Mar 16
|
US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results
|
|
Mar 15
|
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
|
|
Mar 14
|
Q4 2023 ADC Therapeutics SA Earnings Call
|
|
Mar 13
|
ADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Reset
|
|
Mar 13
|
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 13
|
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
|
|
Mar 11
|
Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?
|
|
Mar 6
|
Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
|
|
Mar 6
|
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
|
|
Mar 6
|
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
|
|
Mar 5
|
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
|
|
Feb 27
|
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
|
|
Jan 19
|
ADC Therapeutics (ADCT) Rises 43% in a Month: Here's Why
|
|
Jan 19
|
Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?
|
|
Jan 4
|
ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
|
|
Jan 4
|
ADC Therapeutics Provides Business Updates
|